- Home
- CII vs NKTR Comparison
CII vs NKTR Comparison
Compare CII & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CII | NKTR |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 963.2M | 807.8M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | CII | NKTR |
|---|---|---|
| Price | $22.54 | $72.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $122.33 |
| AVG Volume (30 Days) | 78.8K | ★ 1.4M |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | ★ 6.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $62,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.76 | $6.48 |
| 52 Week High | $19.81 | $72.31 |
Technical Indicators
Market Signals| Indicator | CII | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 36.18 | 80.35 |
| Support Level | $22.39 | $34.47 |
| Resistance Level | $23.25 | $72.31 |
| Average True Range (ATR) | 0.32 | 4.11 |
| MACD | -0.04 | 4.43 |
| Stochastic Oscillator | 8.25 | 94.81 |
Price Performance
Historical ComparisonAbout CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.